Synergistic Mechanism of Functional Foods Rich in Active Peptides in Tumor Immunotherapy

Authors

  • Weijia Liu Department of life sciences, College of Science and Technology Changchun, Changchun, 130000, China

DOI:

https://doi.org/10.54097/gmc8jp11

Keywords:

Tumor immunotherapy; active peptides; synergistic mechanism.

Abstract

Given that traditional tumor therapy is associated with recurrence risk and immunotherapy is limited by the tumor immune microenvironment, alternative adjuvant approaches are urgently needed. In this context, active peptide-functional foods have emerged as promising auxiliary resources, yet their synergistic anti-tumor mechanisms are still not well understood, necessitating further research. In this paper, the dual functions of active peptides in direct tumor suppression and bidirectional regulation of immunity were analyzed. The synergistic principle of inducing immunogenic cell death and activating systemic anti-tumor immunity was elucidated by Gramicidin S and its light-controlled derivatives. Four types of synergistic methods, including molecular modification, light-controlled administration, combination therapy, and nanocarriers, were summarized. It was pointed out that these peptides had problems such as lack of preparation standards and only stopping in vitro experiments. This study clarified the mechanism of active peptide combined with immunotherapy, and provided theoretical support for the development of anti-tumor active peptide food. The existing in vivo pharmacological data are insufficient, and the Immunogenic cell death (ICD) regulatory pathway can be further analyzed in the future, so as to improve the in vivo efficacy and standardized production research and promote its clinical transformation.

Downloads

Download data is not yet available.

References

[1] Ye H, Liao W, Pan J, et al. Immune checkpoint blockade for cancer therapy: current progress and perspectives. Journal of Zhejiang University Science B, 2025, 26(3): 203-226. DOI: https://doi.org/10.1631/jzus.B2300492

[2] Zhang Weiyue, Huang Xin. In vivo gene editing and in situ generation of chimeric antigen receptor cells for next-generation cancer immunotherapy. Journal of Hematology & Oncology, 2024, 17: 110. DOI: https://doi.org/10.1186/s13045-024-01633-7

[3] Kumar Anant, Dixit Shrinket, Srinivasan Kathiravan, et al. Personalized cancer vaccine design using AI-powered technologies. Frontiers in Immunology, 2024, 15: 1357217. DOI: https://doi.org/10.3389/fimmu.2024.1357217

[4] Cheng Shigao, Wang Huiyuan, Kang Xuejia, Zhang Hui. Immunotherapy innovations in the fight against osteosarcoma: emerging strategies and promising progress. Pharmaceutics, 2024, 16(2): 251. DOI: https://doi.org/10.3390/pharmaceutics16020251

[5] Li Sinan, Wang Xi, An Yu, et al. Research Progress on the Preparation, Physiological Activity and Action Mechanism of Plant Derived Bioactive Peptides. Science and Technology of Food Industry, 2025, 46(3): 394-402.

[6] Liu Hanmeng, Shen Wei, Liu Wanguo, et al. From oncolytic peptides to oncolytic polymers: a new paradigm for oncotherapy. Bioactive Materials, 2024, 31: 206-230. DOI: https://doi.org/10.1016/j.bioactmat.2023.08.007

[7] Kwon Yong-Jin, Lee Juno, Seo Eun-Bi, et al. Cysteine protease I29 propeptide from Calotropis procera R. Br. as a potent cathepsin L inhibitor and its suppressive activity in breast cancer metastasis. Scientific Reports, 2024, 14: 23218. DOI: https://doi.org/10.1038/s41598-024-73578-3

[8] Liang Yongyi, Wang Hong, Bai Weidong, Xiao Gengsheng, Zeng Xiaofang. Research progress of animal protein-derived immunomodulatory peptides. Science and Technology of Food Industry, 2023, 44(18): 492-501.(in Chinese)

[9] Kong X, Vishwanath V, Neelakantan P, Ye Z. Harnessing antimicrobial peptides in endodontics. International Endodontic Journal, 2024, 57(3): 815-840. DOI: https://doi.org/10.1111/iej.14043

[10] Liu Y, Chang R, Xing R R, Yan X H. Bioactive peptide nanodrugs based on supramolecular assembly for boosting immunogenic cell death-induced cancer immunotherapy. Small Methods, 2023, 7(5): e2201708. DOI: https://doi.org/10.1002/smtd.202201708

[11] Ye J Y, Gao J, Wang D G, Yu H J. Recent advances of nanosized drug delivery systems targeting immune checkpoints for combination cancer immunotherapy. Science China Life Sciences, 2021, 51(7): 829-845.(in Chinese) DOI: https://doi.org/10.1360/SSV-2019-0221

Downloads

Published

15-11-2026

Issue

Section

Articles

How to Cite

Liu , W. (2026). Synergistic Mechanism of Functional Foods Rich in Active Peptides in Tumor Immunotherapy. International Journal of Biology and Life Sciences, 17(2), 27-31. https://doi.org/10.54097/gmc8jp11